DE69404974D1 - (s)-alpha-phenyl-2-pyridinethanamin(s)-malat und seine verwendung als arzneimittel - Google Patents
(s)-alpha-phenyl-2-pyridinethanamin(s)-malat und seine verwendung als arzneimittelInfo
- Publication number
- DE69404974D1 DE69404974D1 DE69404974T DE69404974T DE69404974D1 DE 69404974 D1 DE69404974 D1 DE 69404974D1 DE 69404974 T DE69404974 T DE 69404974T DE 69404974 T DE69404974 T DE 69404974T DE 69404974 D1 DE69404974 D1 DE 69404974D1
- Authority
- DE
- Germany
- Prior art keywords
- malate
- alpha
- phenyl
- pyridinethanamine
- medicinal product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/GB1993/000689 WO1993020052A1 (en) | 1992-04-03 | 1993-04-01 | Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders |
| GB939320273A GB9320273D0 (en) | 1993-04-01 | 1993-10-01 | Compound useful in therapy |
| PCT/GB1994/000651 WO1994022831A1 (en) | 1993-04-01 | 1994-03-29 | (s)-alpha-phenyl-2-pyridineethanamine (s)-malate and its use as a medicament |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69404974D1 true DE69404974D1 (de) | 1997-09-18 |
| DE69404974T2 DE69404974T2 (de) | 1997-12-18 |
Family
ID=26302299
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69404974T Expired - Lifetime DE69404974T2 (de) | 1993-04-01 | 1994-03-29 | (s)-alpha-phenyl-2-pyridinethanamin(s)-malat und seine verwendung als arzneimittel |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0691957B1 (de) |
| JP (1) | JP3023987B2 (de) |
| CN (1) | CN1047168C (de) |
| AT (1) | ATE156813T1 (de) |
| AU (1) | AU682348B2 (de) |
| CA (1) | CA2159478C (de) |
| DE (1) | DE69404974T2 (de) |
| DK (1) | DK0691957T3 (de) |
| DZ (1) | DZ1765A1 (de) |
| ES (1) | ES2105672T3 (de) |
| FI (1) | FI109018B (de) |
| GB (1) | GB9320273D0 (de) |
| GR (1) | GR3025081T3 (de) |
| IL (1) | IL109108A (de) |
| MA (1) | MA23154A1 (de) |
| NO (1) | NO304647B1 (de) |
| PH (1) | PH30950A (de) |
| SG (1) | SG48204A1 (de) |
| WO (1) | WO1994022831A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0648489A1 (de) * | 1988-08-12 | 1995-04-19 | Fisons Corporation | Arylalkylamide die nervenschützende Eigenschaften besitzen |
| ZA942140B (en) * | 1993-04-01 | 1994-10-03 | Fisons Corp | Salt of (S)-alpha-phenyl-2-pyridineethanamine useful in therapy |
| SE9901340D0 (sv) * | 1999-04-15 | 1999-04-15 | Astra Pharma Prod | Novel process |
| SE9901338D0 (sv) * | 1999-04-15 | 1999-04-15 | Astra Pharma Prod | Novel process |
| DE10301650A1 (de) * | 2003-01-17 | 2004-07-29 | Johannes-Gutenberg-Universität Mainz | Medizinisch nützliche 1-Phenyl-2-aminomethylnaphthaline, Verfahren zu ihrer Herstellung, sie enthaltende Arzneimittel und deren Verwendung |
| AU2009330745B2 (en) | 2008-12-24 | 2012-04-05 | Astrazeneca Ab | Ethanamine compounds and their use for treating depression |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3422191A (en) * | 1965-01-21 | 1969-01-14 | Synergistics Inc | Compositions and methods for tranquilization employing salts of n-morpholine ethanol |
| EP0648489A1 (de) * | 1988-08-12 | 1995-04-19 | Fisons Corporation | Arylalkylamide die nervenschützende Eigenschaften besitzen |
| JP2514855B2 (ja) * | 1990-08-08 | 1996-07-10 | キッセイ薬品工業株式会社 | 光学活性なアラニンアニリド誘導体の酸付加塩 |
| AU3897693A (en) * | 1992-04-03 | 1993-11-08 | Astra Aktiebolag | Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders |
-
1993
- 1993-10-01 GB GB939320273A patent/GB9320273D0/en active Pending
-
1994
- 1994-03-24 IL IL10910894A patent/IL109108A/en not_active IP Right Cessation
- 1994-03-29 EP EP94911232A patent/EP0691957B1/de not_active Expired - Lifetime
- 1994-03-29 SG SG1996007883A patent/SG48204A1/en unknown
- 1994-03-29 DK DK94911232.0T patent/DK0691957T3/da active
- 1994-03-29 WO PCT/GB1994/000651 patent/WO1994022831A1/en active IP Right Grant
- 1994-03-29 AU AU63802/94A patent/AU682348B2/en not_active Expired
- 1994-03-29 PH PH48016A patent/PH30950A/en unknown
- 1994-03-29 JP JP6521814A patent/JP3023987B2/ja not_active Expired - Lifetime
- 1994-03-29 AT AT94911232T patent/ATE156813T1/de active
- 1994-03-29 ES ES94911232T patent/ES2105672T3/es not_active Expired - Lifetime
- 1994-03-29 DE DE69404974T patent/DE69404974T2/de not_active Expired - Lifetime
- 1994-03-29 CA CA002159478A patent/CA2159478C/en not_active Expired - Lifetime
- 1994-03-30 DZ DZ940029A patent/DZ1765A1/fr active
- 1994-04-01 MA MA23459A patent/MA23154A1/fr unknown
- 1994-04-01 CN CN94103739A patent/CN1047168C/zh not_active Expired - Lifetime
-
1995
- 1995-09-28 NO NO951546A patent/NO304647B1/no not_active IP Right Cessation
- 1995-09-29 FI FI954645A patent/FI109018B/fi not_active IP Right Cessation
-
1997
- 1997-10-17 GR GR970402722T patent/GR3025081T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO953846L (no) | 1995-11-21 |
| CN1047168C (zh) | 1999-12-08 |
| EP0691957A1 (de) | 1996-01-17 |
| CN1098095A (zh) | 1995-02-01 |
| DK0691957T3 (da) | 1997-10-27 |
| WO1994022831A1 (en) | 1994-10-13 |
| MA23154A1 (fr) | 1994-12-31 |
| PH30950A (en) | 1997-12-23 |
| DZ1765A1 (fr) | 2002-02-17 |
| AU6380294A (en) | 1994-10-24 |
| EP0691957B1 (de) | 1997-08-13 |
| ATE156813T1 (de) | 1997-08-15 |
| SG48204A1 (en) | 1998-04-17 |
| GR3025081T3 (en) | 1998-01-30 |
| CA2159478C (en) | 2005-01-25 |
| JPH08508292A (ja) | 1996-09-03 |
| NO953846D0 (no) | 1995-09-28 |
| JP3023987B2 (ja) | 2000-03-21 |
| AU682348B2 (en) | 1997-10-02 |
| GB9320273D0 (en) | 1993-11-17 |
| FI954645A (fi) | 1995-11-29 |
| FI109018B (fi) | 2002-05-15 |
| FI954645A0 (fi) | 1995-09-29 |
| CA2159478A1 (en) | 1994-10-13 |
| DE69404974T2 (de) | 1997-12-18 |
| NO304647B1 (no) | 1999-01-25 |
| IL109108A0 (en) | 1994-06-24 |
| IL109108A (en) | 1999-01-26 |
| ES2105672T3 (es) | 1997-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69128316D1 (de) | Deodorant und dieses enthaltendes Produkt | |
| GR980300033T1 (en) | Compositions for the treatment of dermatological disorders and methods for their use | |
| AU5756194A (en) | Cosmetic applicator useful for cleansing, moisturizing and protecting the skin from diaper rash | |
| DE69600048D1 (de) | Kosmetisches Haarwaschmittel und dessen Verwendung | |
| ATE215373T1 (de) | 21-hydro-6,19-oxidoprogesterone (21oh-60p) und deren verwendung als arzneimittel zur behandlung von glukokortikoidüberschuss | |
| DE69333072D1 (de) | Topisch anzuwendendes arzneimittel enthaltend hyaluronsäure und nsaids | |
| DE69532066D1 (de) | Arzneimittel zur Behandlung von Restenosis und Gefässsklerose | |
| ATE156813T1 (de) | (s)-alpha-phenyl-2-pyridinethanamin(s)-malat und seine verwendung als arzneimittel | |
| DE69528165D1 (de) | Transdermal verabreichbare grundlage und daraus hergestelltes transdermal verabreichbares arzneimittel | |
| KR960702749A (ko) | 심장혈관 질환의 치료를 위한 천연물 및 이와 관련된 합성 화합물의 사용(Use of Natural Products and Related Synthetic Compounds for the Treatment of Cardiovascular Disease) | |
| NO171798C (no) | Fremgangsmaate for behandling av sinkholdige biprodukter og avfallsmaterialer | |
| NO952568D0 (no) | Behandling av cellulosemateriale og blandinger for anvendelse for dette | |
| DE59410107D1 (de) | Chinoxaline und arzneimittel daraus | |
| AU5963396A (en) | Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders | |
| ATE156814T1 (de) | (s)-alpha-phenyl-2-pyridinethanamin benzoat und seine verwendung als arzneimittel | |
| FR2733418B1 (fr) | Nouvelles associations comprenant du (-) hydroxycitrate et presentant notamment de nouvelles activites therapeutiques | |
| EP0731064A3 (de) | Aufarbeitung und Verwendung der Rückstände der Direkten Synthese von Organochlor- u./o. Chlorsilanen | |
| EP0502470A3 (en) | Compounds for the treatment of inflammation and allergy | |
| AU5553294A (en) | Novel substance dolastatin c and pharmaceutical use thereof | |
| BA95039A (bs) | Set za prevenciju i terapiju bolne menstruacije | |
| GB9312780D0 (en) | Therapeutic and cosmetic treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |